Moderna expands pipeline to include liver disease programs; Imperial researchers team up with Heptares on gastrointestinal diseases
→ Moderna‘s pipeline now includes 19 mRNA drug candidates, including two new liver disease programs and 10 drugs in the clinic. New programs include mRNA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
